Infringement Analysis in Copenhagen.

A patent infringement analysis Copenhagen litigators can act on has to be built for two courts at once — the specialist Maritime and Commercial High Court that has heard Danish patent cases for generations, and the Copenhagen Local Division of the Unified Patent Court that now sits alongside it. Copenhagen is the capital of Denmark and the anchor of Medicon Valley, the cross-border life-science cluster that runs across the Øresund to Malmö and Lund and clusters Novo Nordisk, Lundbeck, Genmab, Coloplast and a deep bench of biotech and medtech around the city. The patents fought over here read on formulations, antibodies, second medical uses, devices and cleantech systems, and every case turns on whether the accused product actually practises the claim. PerspireIP builds the claim charts and evidence-of-use that prove — or defeat — that link.

Where a patent infringement analysis Copenhagen case is decided

Denmark channels its patent disputes into one specialist forum. First-instance patent infringement and validity actions are brought before the Maritime and Commercial High Court (Sø- og Handelsretten) in Copenhagen, a court founded in 1861 that hears the country’s technically demanding commercial and IP cases. Its strength is the bench itself: patent matters are decided by a panel of one or three legally trained judges sitting with two or four technical expert assessors drawn from a standing pool of roughly 140, so the tribunal that reads your claim chart genuinely understands the technology behind it.

A judgment of the Maritime and Commercial High Court is appealed to the High Court of Eastern Denmark (Østre Landsret), since Copenhagen sits in the eastern judicial district, and in exceptional cases can go directly to the Supreme Court. A further appeal to the Supreme Court (Højesteret) requires leave from the Appeals Permission Board. Because infringement and any invalidity defence are weighed together in the same action, and new evidence is admitted on appeal, the mapping of the accused product onto the claim has to be litigation-ready from the first filing.

• Maritime and Commercial High Court (Sø- og Handelsretten) — the first-instance patent forum in Copenhagen, sitting with technical expert assessors
• High Court of Eastern Denmark (Østre Landsret) — the appellate court for cases from the Copenhagen district
• Supreme Court (Højesteret) — the final instance, reached with leave from the Appeals Permission Board
• DKPTO (Danish Patent and Trademark Office) — the national office that grants and validates the patents being enforced

Denmark inside the UPC: the Copenhagen Local Division

What sets Copenhagen apart from many European venues is that a patentee here has a genuine choice of court. Denmark ratified the Unified Patent Court Agreement after a national referendum approved membership in 2014, and it is a full participant in the Unitary Patent system. Since the UPC opened, Denmark has hosted the Copenhagen Local Division of the Unified Patent Court, which sits in the very premises of the Maritime and Commercial High Court at Amaliegade 35.

The Local Division can hear an infringement action where the alleged infringement occurs in Denmark or where the defendant is based here, and Denmark has designated both Danish and English as languages of proceedings — a practical advantage for the international life-science companies that dominate the region. A Unitary Patent, or a classical European patent that has not been opted out, can be enforced across all participating states in a single Copenhagen action, and the same court can revoke it with the same reach.

That dual system reshapes the analysis. A patentee may assert a Danish national patent, or the Danish part of a European bundle, before the Maritime and Commercial High Court, or run a Unitary Patent through the UPC for pan-European effect — and an accused party has to weigh a national defence against a UPC counterclaim for revocation. The strategic choice of forum, opt-out status and bifurcation risk all sit on top of one constant: an element-by-element read of whether the accused product infringes. That read is the foundation the forum decision is built on.

Medicon Valley: what the asserted patents claim

Copenhagen’s litigation profile is written by Medicon Valley, one of Europe’s densest life-science clusters. Linked physically by the Øresund Bridge and institutionally by the Medicon Valley Alliance, the region spans Greater Copenhagen and the Swedish side around Malmö and Lund, and packs more than 350 pharma, biotech and medtech companies into a single metropolitan area. The Copenhagen anchors are household names in the sector — Novo Nordisk in diabetes and obesity, Lundbeck in neuroscience, Genmab in antibody therapeutics, LEO Pharma, Ferring, ALK-Abelló, Zealand Pharma and Bavarian Nordic.

Pharma and biotech are the most litigated patent fields in Denmark, and the asserted claims read on formulations, salts and polymorphs, antibody sequences and platforms, second-medical-use indications, dosage regimens and biologics manufacturing processes. Recent Danish patent battles — a preliminary injunction for Bristol-Myers Squibb against Teva, and a Biogen action against Sandoz limited to relapsing-remitting multiple sclerosis — show how these cases turn on the precise scope of the claim against a specific marketed product.

Around the therapeutics core sits a strong medtech base led by Coloplast and Ambu, whose patents cover devices, single-use instruments and connected systems, and a growing cleantech stream anchored by Ørsted in offshore wind with Vestas nearby, generating turbine, control and energy-system patents. Whether the technology is an antibody, a dosage regimen, an ostomy device or a wind-turbine control system, the commercial question is identical: does the accused product fall within the scope of the asserted claim? Answering it is exactly what an infringement analysis does.

Securing evidence in Denmark before you sue

Danish law gives a patentee a route to lock down proof before a full trial. Where infringement evidence risks being altered or destroyed, a party can apply for the court-supervised securing of evidence (bevissikring) under the Administration of Justice Act — a proceeding, akin to an isolated taking of evidence, that lets the court inspect and document an alleged infringer’s products, machinery and records. It is granted where infringement is rendered probable and the evidence cannot practically be obtained another way, and it exists precisely for cases where the infringing act happens behind a factory door or inside a manufacturing process.

The court frames the measure to capture what proves the claim while protecting unrelated trade secrets, and the material gathered then feeds directly into the infringement case. Denmark also sits outside the EU evidence-taking regulation, so cross-border evidence runs through the Hague Evidence Convention — a wrinkle that matters when the accused product or its manufacture reaches across the Øresund or beyond.

None of it works without a claim map first. A court asked to send inspectors into a competitor’s premises needs a clear, element-by-element showing of why the accused product is presumed to read on the claim — what to look for, and where. That mapping is the deliverable, and it has to be ready before the securing-of-evidence request is even filed. The same discipline applies to the UPC’s own order-to-preserve-evidence and inspection measures, which a Copenhagen Local Division claimant can seek on the same evidentiary footing.

How claim charts carry a Danish infringement action

Whether you are asserting a patent or defending against one, the case is won or lost on a single document: the claim chart that maps each element of the asserted claim onto the accused product or process. In a Maritime and Commercial High Court action, and equally before the Copenhagen Local Division, the court expects that mapping to be concrete — tied to the marketed formulation, the antibody, the device or the turbine control — and backed by evidence-of-use that survives cross-examination and any invalidity counterattack.

• Element-by-element claim charts mapping every limitation of the asserted claim to the accused product or process
• Evidence-of-use built from product teardowns, laboratory analysis, technical datasheets, regulatory dossiers and public technical literature
• Doctrine-of-equivalents analysis where the accused product is not a literal match, argued to Danish and European Patent Convention standards
• Non-infringement and freedom-to-operate positions for an accused Danish manufacturer, with claim construction pinned to the prosecution history
• A package scoped to the forum — a national complaint, a preliminary-injunction application, or a UPC filing before the Copenhagen Local Division

Preliminary injunctions are a live part of Danish practice under Chapter 40 of the Administration of Justice Act: the patentee must render probable a valid, infringed patent and a real need for urgent relief, usually posting security such as a bank guarantee, and ex parte orders are available where urgency is proven. Every one of these tools — national or UPC, interim or final — rests on the same rigorous, evidence-backed claim chart, not on a conclusion asserted without proof.

How PerspireIP builds a Copenhagen infringement-analysis file

Every engagement follows the same disciplined path. We construct the claim scope first, fixing the correct construction from the claims, specification and prosecution history, then map each element against the real accused product or process. For pharma and biotech we work from formulations, polymorph and antibody data and regulatory dossiers; for medtech from device teardowns and technical datasheets; for cleantech from system and control evidence — charting infringement literally and, where needed, under the doctrine of equivalents.

• Claim construction and element-by-element charting to Danish Patents Act, UPC and EPC standards
• Evidence-of-use assembly — teardowns, lab analysis, datasheets, regulatory and public technical sources — dated and documented
• Infringement and non-infringement positions built for either side of a Maritime and Commercial High Court or UPC dispute
• Deliverables scoped to your forum: a national complaint, a preliminary injunction, or a Copenhagen Local Division filing
• Support for a securing-of-evidence application and coordination with parallel proceedings across the Unitary Patent system

We work alongside your Danish and European counsel as a specialist analysis partner, deliver to Maritime and Commercial High Court, UPC and DKPTO deadlines, and keep every engagement confidential. Whether you are a Medicon Valley pharma, biotech, medtech or cleantech company enforcing a patent, an accused party clearing a path to market, or litigation counsel preparing a complaint or a defence, we scale to fit — a single claim chart, a multi-patent matter or ongoing portfolio support. Send us the patent number and the accused product, and we will scope a patent infringement analysis Copenhagen project within one business day.

IP Landscape & Resources in Copenhagen

Key intellectual-property authorities and venues relevant to Copenhagen:

• DKPTO (Danish Patent and Trademark Office) — the Danish national office (Patent- og Varemærkestyrelsen) that grants Danish patents and validates European patents enforced in Copenhagen
• Unified Patent Court — the court whose Copenhagen Local Division hears Unitary Patent and European patent infringement actions in Denmark in Danish or English
• Danish Courts (Domstolsstyrelsen) — the official portal of the Danish judiciary, including the Maritime and Commercial High Court, the High Court of Eastern Denmark and the Supreme Court
• European Patent Office (EPO) — grants the European and Unitary Patents that are validated and enforced in Denmark through the national courts and the UPC

Request a Patent Infringement Analysis in Copenhagen

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions